Recombinant NY-ESO-1 Protein

A genetically engineered synthetic protein, Recombinant NY-ESO-1 Protein (Cancer-Testis Tumor Antigen Family) elicits strong humoral and cellular… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2013
01220072013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
NY‑ESO‑1 is one of the most immunogenic cancer-testis (CT) antigens. Cancer vaccine trials based on NY‑ESO‑1 are currently… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
The synthetic oligodeoxynucleotide CpG 7909, which contains unmethylated cytosine/guanine (CpG) motifs, has potent… (More)
Is this relevant?
2011
2011
PURPOSE NY-ESO-1, one of the most immunogenic tumor antigens, is expressed in 15% to 25% of metastatic prostate cancers. The… (More)
Is this relevant?
2009
2009
PURPOSE ESO is a tumor-specific antigen with wide expression in human tumors of different histologic types and remarkable… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2009
2009
PURPOSE NY-ESO-1 is a highly immunogenic antigen expressed in a variety of malignancies, making it an excellent target for cancer… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The use of recombinant tumor antigen proteins is a realistic approach for the development of generic cancer vaccines, but the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?